AzTrials
AzTrials

SyncopeNCT05575934

Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department

An observational study of Syncope and Unconscious State, run by University Hospital, Clermont-Ferrand at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study is to examine the clinical presentations, the diagnostic tests performed and the management of patients presenting with transient loss of consciousness (TLOC) The main questions it aims to answer are: prevalence of TLOC prevalence of different diagnoses leading to TLOC Demographic… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Syncope, Unconscious State
How many people
250 participants
Where
1 siteFrance
Study dates
3 Oct 2022to 30 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All adult patients presenting to the emergency room of the CHU de Clermont-Ferrand with a transient loss of consciousness of syncopal or undifferentiated origin will be included once the non-objection has been collected.

Who may be able to join

  • patients over 18 presenting to the Clermont-Ferrand University Hospital emergency department for transient loss of consciousness of syncopal or undifferentiated origin

Who cannot join

  • N/A

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU Clermont-Ferrand

    Clermont-Ferrand, 63003

    Lise Laclautre, promo_interne_drci@chu-clermontferrand.fr

    Fares Moustafa, MD, PhD

    Recruiting

Other trials in France

About this study

The goal of this observational study is to examine the clinical presentations, the diagnostic tests performed and the management of patients presenting with transient loss of consciousness (TLOC)

The main questions it aims to answer are:

  • prevalence of TLOC
  • prevalence of different diagnoses leading to TLOC Demographic, clinical, paraclinical and biological data will be collected from the emergency medical file
Read the detailed description

Patients over the age of 18 presenting to the University Hospital of Clermont-Ferrand emergency department for transient loss of consciousness of syncopal or undifferentiated origin will be include. Their non-opposition will be sought.

Demographic, clinical, paraclinical and biological data will be collected from the emergency medical file.

No visit is planned after the passage to the emergency room.

Keywords
transient loss of consciousness, syncope, emergency department
Medical subject headings
Syncope, Unconsciousness, Emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. prevalence of transient loss of consciousness in emergency department

    Percentage of TLOC in emergency department

    Measured: through the study duration, an average of 6 months

  2. prevalence of different diagnoses leading to transient loss of consciousness

    Percentage of different diagnoses leading to transient loss of consciousness

    Measured: through the study duration, an average of 6 months

Secondary outcomes (2)
  1. prevalence of different clinical presentations of loss of consciousness

    Percentage of different clinical presentations of loss of consciousness

    Measured: through the study duration, an average of 6 months

  2. Prevalence of the various diagnostic tests carried out and the treatment of patients presenting for transient loss of consciousness

    Percentage of the various diagnostic tests carried out and the treatment of patients presenting for transient loss of consciousness

    Measured: through the study duration, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2022
  2. Study start3 Oct 2022
  3. Primary completion25 Mar 2023 (estimated)
  4. Study completion30 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05575934
Sponsor's protocol ID
EI22MG0908
Status last verified
Oct 2022
First submitted
4 Oct 2022
Last updated
12 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Syncope and Unconscious State, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lise Laclautre (334.73.754.963, promo_interne_drci@chu-clermontferrand.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

prevalence of transient loss of consciousness in emergency department (time frame: through the study duration, an average of 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in